Literature DB >> 10735688

Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery.

S Sirivella1, I Gielchinsky, V Parsonnet.   

Abstract

BACKGROUND: Acute renal failure occurring in the postoperative period, requiring dialysis after cardiac surgery is an important risk factor for an early mortality, and the overall mortality of this complication is as high as 40% to 60%. Dialysis in the early postoperative period is often complicated by acute hemodynamic, metabolic, and hematologic effects that adversely affect cardiopulmonary function in patients stabilizing from recent surgery. The purpose of this study was to avoid the need for dialysis by infusion of the solution of mannitol, furosemide, and dopamine in the early postoperative period in oliguric renal failure.
METHODS: One hundred patients with postoperative oliguric or anuric renal failure despite adequate postoperative cardiac output and hemodynamic function were randomized. Forty patients (group A) were given intermittent doses of diuretics (furosemide, bumetadine, and ethracrynic acid) and fluids. Sixty patients (group B) were given continuous infusion of the solution of mannitol, furosemide, and dopamine; the infusion was started within 6 hours (mean 3.5 hours) in subgroup B1 (n = 30), and later than 6 hours (mean 7.5 hours) in subgroup B2 (n = 30) after the onset of renal failure.
RESULTS: Diuresis occurred in 93.3% of group B (n = 56) versus 10% in group A (n = 4; patients with preop normal renal function). Ninety percent of group A (n = 36) required dialysis versus only 6.7% of group B (n = 4; patients with preexisting renal disease of subgroup B2). Renal function returned to preoperative normal (serum creatinine 0.9 +/- 0.05, p < 0.0001) or baseline value (serum creatinine 2.5 +/- 0.01, p < 0.0001) after first postoperative week in subgroup B1 and third postoperative week in subgroup B2.
CONCLUSIONS: Infusion of solution of mannitol, furosemide, and dopamine promoted diuresis in patients with acute postoperative renal failure with adequate postoperative cardiac output and had decreased the need for dialysis in the majority of patients. Early administration of this solution in acute renal failure caused early restoration of renal function to normal or baseline status. It remains to be determined whether routine administration of this solution in the early postoperative period for oliguric renal failure influences the long-term mortality and morbidity in those patients who do require dialysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10735688     DOI: 10.1016/s0003-4975(99)01298-9

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  25 in total

1.  Low-dose carperitide (α-human A-type natriuretic peptide) alleviates hemoglobin concentration decrease during prolonged oral surgery: a randomized controlled study.

Authors:  Masanori Tsukamoto; Sayuri Koyama; Kanako Esaki; Takashi Hitosugi; Takeshi Yokoyama
Journal:  J Anesth       Date:  2017-01-30       Impact factor: 2.078

Review 2.  Acute renal failure in children: aetiology and management.

Authors:  G Filler
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  Prevention and treatment of acute kidney injury in patients undergoing cardiac surgery: a systematic review.

Authors:  Meyeon Park; Steven G Coca; Sagar U Nigwekar; Amit X Garg; Susan Garwood; Chirag R Parikh
Journal:  Am J Nephrol       Date:  2010-04-06       Impact factor: 3.754

4.  The efficacy of tolvaptan in the perioperative management of chronic kidney disease patients undergoing open-heart surgery.

Authors:  Mitsutomo Yamada; Hiroyuki Nishi; Naosumi Sekiya; Kohei Horikawa; Toshiki Takahashi; Yoshiki Sawa
Journal:  Surg Today       Date:  2016-08-23       Impact factor: 2.549

5.  Continuous renal replacement therapy versus furosemide for management of kidney impairment in heart transplant recipients with volume overload.

Authors:  Seyed Mohsen Mirhosseini; Mohammad Fakhri; Shadi Asadollahi; Zargham Hossein Ahmadi; Farin Rashid Farokhi; Mohammad Reza Boloursaz; Mohammad Reza Masjedi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-12-05

6.  The use of mannitol in partial and live donor nephrectomy: an international survey.

Authors:  M Cosentino; A Breda; F Sanguedolce; J Landman; J-U Stolzenburg; P Verze; J Rassweiler; H Van Poppel; H C Klingler; G Janetschek; A Celia; F J Kim; G Thalmann; U Nagele; A Mogorovich; C Bolenz; T Knoll; F Porpiglia; M Alvarez-Maestro; F Francesca; F Deho; S Eggener; C Abbou; M V Meng; M Aron; P Laguna; D Mladenov; A D'Addessi; P Bove; R Schiavina; O De Cobelli; A S Merseburger; O Dalpiaz; F C H D'Ancona; T J Polascik; R Muschter; T J Leppert; H Villavicencio
Journal:  World J Urol       Date:  2012-12-15       Impact factor: 4.226

7.  The SPARK Study: a phase II randomized blinded controlled trial of the effect of furosemide in critically ill patients with early acute kidney injury.

Authors:  Sean M Bagshaw; R T Noel Gibney; Finlay A McAlister; Rinaldo Bellomo
Journal:  Trials       Date:  2010-05-11       Impact factor: 2.279

Review 8.  Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM.

Authors:  Michael Joannidis; Wilfred Druml; Lui G Forni; A B Johan Groeneveld; Patrick Honore; Heleen M Oudemans-van Straaten; Claudio Ronco; Marie R C Schetz; Arend Jan Woittiez
Journal:  Intensive Care Med       Date:  2010-03       Impact factor: 17.440

9.  Effects of tolvaptan in the early postoperative stage after heart valve surgery: results of the STAR (Study of Tolvaptan for fluid retention AfteR valve surgery) trial.

Authors:  Hiroyuki Nishi; Koichi Toda; Shigeru Miyagawa; Yasushi Yoshikawa; Satsuki Fukushima; Masashi Kawamura; Daisuke Yoshioka; Tetsuya Saito; Takayoshi Ueno; Toru Kuratani; Yoshiki Sawa
Journal:  Surg Today       Date:  2015-09-28       Impact factor: 2.549

10.  A perioperative strategy for abdominal aortic aneurysm in patients with chronic renal insufficiency.

Authors:  Makoto Haga; Katsuyuki Hoshina; Kunihiro Shigematsu; Toshiaki Watanabe
Journal:  Surg Today       Date:  2015-12-08       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.